Cargando…

Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma

BACKGROUND: Activation of Wnt/β-catenin pathway is a frequent event in hepatocellular carcinoma and is associated with enhanced cell survival and proliferation. Therefore, targeting this signaling pathway is discussed as an attractive therapeutic approach for HCC treatment. BCL9 and BCL9L, two homol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huge, Nicole, Sandbothe, Maria, Schröder, Anna K., Stalke, Amelie, Eilers, Marlies, Schäffer, Vera, Schlegelberger, Brigitte, Illig, Thomas, Vajen, Beate, Skawran, Britta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220899/ https://www.ncbi.nlm.nih.gov/pubmed/31440992 http://dx.doi.org/10.1007/s12072-019-09977-w

Ejemplares similares

Ago-RIP Sequencing Identifies New MicroRNA-449a-5p Target Genes Increasing Sorafenib Efficacy in Hepatocellular Carcinoma
por: Reinkens, Thea, et al.
Publicado: (2022)

MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF
por: Huge, Nicole, et al.
Publicado: (2022)

MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation
por: Vajen, Beate, et al.
Publicado: (2022)

HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma
por: Buurman, Reena, et al.
Publicado: (2016)

BCL9/BCL9L in hepatocellular carcinoma: Will it or Wnt it be the next therapeutic target?
por: Moghe, Akshata, et al.
Publicado: (2020)

Functional characterization of a JAG1 5'UTR variant in a patient with clinically observed Alagille syndrome
por: Buhl, Nicole, et al.
Publicado: (2022)

Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9
por: van Tienen, Laurens M, et al.
Publicado: (2017)

Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells
por: Kotolloshi, Roland, et al.
Publicado: (2022)

The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells
por: de la Roche, Marc, et al.
Publicado: (2008)

Correction: Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9
por: van Tienen, Laurens M, et al.
Publicado: (2017)

Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer
por: Gay, David M., et al.
Publicado: (2019)

The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities
por: Wu, Minjie, et al.
Publicado: (2023)

A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
por: Tanton, Helen, et al.
Publicado: (2022)

Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia
por: Vajen, Beate, et al.
Publicado: (2013)

Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma
por: Hyeon, Jiyeon, et al.
Publicado: (2013)

Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2017)

The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis
por: Vafaizadeh, Vida, et al.
Publicado: (2021)

The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis
por: Zatula, Nathalie, et al.
Publicado: (2014)

Author Correction: Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer
por: Gay, David M., et al.
Publicado: (2019)

Decoding of Methylated Histone H3 Tail by the Pygo-BCL9 Wnt Signaling Complex
por: Fiedler, Marc, et al.
Publicado: (2008)

Tuning WNT-β-catenin signaling via BCL9 proteins for targeting colorectal cancer cells
por: Beaulieu, Jean-François
Publicado: (2015)

Structural basis of the interaction between BCL9-Pygo and LDB-SSBP complexes in assembling the Wnt enhanceosome
por: Wang, Hongyang, et al.
Publicado: (2023)

Hit-and-run lymphomagenesis by the Bcl6 oncogene
por: Green, Michael R, et al.
Publicado: (2014)

Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling
por: Tao, Bei, et al.
Publicado: (2021)

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

Psychological Distress and Coping Ability of Women at High Risk of Hereditary Breast and Ovarian Cancer before Undergoing Genetic Counseling—An Exploratory Study from Germany
por: Vajen, Beate, et al.
Publicado: (2021)

Bcl-x(L) is an oncogenic driver in colorectal cancer
por: Scherr, Anna-Lena, et al.
Publicado: (2016)

Aristaless Related Homeobox (ARX) Interacts with β-Catenin, BCL9, and P300 to Regulate Canonical Wnt Signaling
por: Cho, Il-Taeg, et al.
Publicado: (2017)

BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer
por: Moor, Andreas E., et al.
Publicado: (2015)

Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling
por: Cantù, Claudio, et al.
Publicado: (2018)

miR‐140‐3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2
por: Liu, Dingsheng, et al.
Publicado: (2021)

Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma
por: Huang, Lining, et al.
Publicado: (2019)

Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2(+) diffuse large B-cell lymphomas
por: Shen, Yajie, et al.
Publicado: (2022)

miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
por: Yang, Chao, et al.
Publicado: (2017)

Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo
por: Karpel-Massler, Georg, et al.
Publicado: (2015)

BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
por: LING, XIAO-HUI, et al.
Publicado: (2016)

Activation of Bcl-2-Caspase-9 Apoptosis Pathway in the Testis of Asthmatic Mice
por: Xu, Wenyuan, et al.
Publicado: (2016)

BCL2 oncogene translocation is mediated by a chi-like consensus
Publicado: (1992)

Targeting Bcl-2 stability to sensitize cells harboring oncogenic ras
por: Peng, Bo, et al.
Publicado: (2015)

BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosis
por: Louwen, Frank, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9fa7c9a80itt5bl91mcl8s2o3t